<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To evaluate the relationship between pulmonary and <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> in patients with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (SS) </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: Eighteen patients with SS prospectively underwent cardiac magnetic resonance imaging (CMR) and high-resolution computed tomography (HRCT) of the chest </plain></SENT>
<SENT sid="2" pm="."><plain>Cardiac biomarkers (N-terminal pro B-type natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi>) and quality-of-life measures (SF-36 and SS health assessment questionnaires) were assessed </plain></SENT>
<SENT sid="3" pm="."><plain>Two readers blinded to other test results evaluated the CMRs in consensus for functional left and right ventricular parameters and for myocardial late enhancement </plain></SENT>
<SENT sid="4" pm="."><plain>HRCT images were reviewed at 5 levels and scored for total disease extent, extent of reticulation, proportion of ground-glass opacities (GGO), and coarseness of reticulation </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Right ventricular ejection fraction correlated significantly with the percentage of late enhancement of the myocardium (R=0.63, P&lt;0.01), extent of <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo> (R=0.57, P&lt;0.01), and extent of GGO (R=0.53, P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Significant correlations were also found between the percentage of late enhancement of the myocardium and the extent of overall <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo> (R=0.59, P&lt;0.05) and the extent of the ground-glass subcomponent (R=0.58, P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>N-terminal pro B-type natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> correlated significantly with the number of myocardial segments with late enhancement (R=0.64, P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Stepwise multiple linear regression revealed the extent of pulmonary GGO to be the only independent predictor of the percentage of myocardial enhancement (R2=0.61, P&lt;0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: In patients with SS with <z:hpo ids='HP_0002206'>pulmonary fibrosis</z:hpo> on HRCT images, CMR may be a useful test to detect early-stage <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> </plain></SENT>
</text></document>